Cargando…

Sarcopenia in pancreatic cancer: Effect on patient outcomes

Pancreatic cancer is a challenging disease with an increasing incidence and extremely poor prognosis. The clinical outcomes of pancreatic cancer depend on tumor biology, responses to treatments, and malnutrition or cachexia. Sarcopenia represents a severe catabolic condition defined by the age-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Moon Hyung, Yoon, Seung Bae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782618/ https://www.ncbi.nlm.nih.gov/pubmed/36568942 http://dx.doi.org/10.4251/wjgo.v14.i12.2302

Ejemplares similares

Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
por: Chan, Miu Yee, et al.
Publicado: (2019)

Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
por: Ko, Sung Woo, et al.
Publicado: (2023)

Exercise therapy for sarcopenia and diabetes
por: Lim, Seung-Taek, et al.
Publicado: (2023)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia
por: Ma, Xiao-Yu, et al.
Publicado: (2021)

Long term oncological outcome of laparoscopic techniques in pancreatic cancer
por: Buanes, Trond, et al.
Publicado: (2018)

Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting
por: Beltrami, Matteo, et al.
Publicado: (2021)

Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
por: Coelho, Marta Paula Pereira, et al.
Publicado: (2023)

Long-term outcomes of autoimmune pancreatitis
por: Ikeura, Tsukasa, et al.
Publicado: (2016)

Preoperative sarcopenia and post‐operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer
por: Choi, Moon Hyung, et al.
Publicado: (2018)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
por: Nishimoto, Arata
Publicado: (2022)

Pancreatic cancer and depression
por: Michoglou, Kalliopi, et al.
Publicado: (2023)

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)

Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations
por: Poddighe, Dimitri
Publicado: (2021)

Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer
por: Petrov, Maxim S
Publicado: (2021)

Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
por: Nardelli, Silvia, et al.
Publicado: (2019)

Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis
por: Kunovsky, Lumir, et al.
Publicado: (2021)

T cells in pancreatic cancer stroma
por: Goulart, Michelle R, et al.
Publicado: (2021)

Interventional strategies in infected necrotizing pancreatitis: Indications, timing, and outcomes
por: Purschke, Birte, et al.
Publicado: (2022)

Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot
por: Kalayarasan, Raja, et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017)

Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
por: Di Carlo, Claudia, et al.
Publicado: (2018)

Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013)

Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms
por: Torisu, Yuichi, et al.
Publicado: (2019)

Endoscopic ultrasonography-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer: An update
por: Pérez-Aguado, Guillermo, et al.
Publicado: (2021)

Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency
por: Layer, Peter, et al.
Publicado: (2019)

Endoscopic ultrasound guided interventions in the management of pancreatic cancer
por: Kerdsirichairat, Tossapol, et al.
Publicado: (2022)

Impact of microbiota-immunity axis in pancreatic cancer management
por: Bartolini, Ilenia, et al.
Publicado: (2022)

Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022)

Current role of palliative interventions in advanced pancreatic cancer
por: Ciambella, Chelsey C, et al.
Publicado: (2018)

Role of human nucleoside transporters in pancreatic cancer and chemoresistance
por: Carter, Carly Jade, et al.
Publicado: (2021)

BRCA mutated pancreatic cancer: A change is coming
por: Rosen, Michael N, et al.
Publicado: (2021)

Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer
por: Salom, Federico, et al.
Publicado: (2022)

Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
por: Sim, Wynne, et al.
Publicado: (2022)

Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer
por: Tsuchikawa, Takahiro, et al.
Publicado: (2016)

Pancreatic cancer: New hopes after first line treatment
por: Aroldi, Francesca, et al.
Publicado: (2016)

Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
por: Kanat, Ozkan, et al.
Publicado: (2018)

Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
por: Yakovenko, Anastasiya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ulr5vc929k3glc8p7ak2eh105v